Target intelligence / Profile preview

SEPTIN7 antisense RNA 1 (SEPT7-AS1)

Target
SEPT7-AS1
Molecular classification
Non-coding RNA, Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

SEPTIN7 antisense RNA 1 (SEPT7-AS1) is a long non-coding RNA transcribed in an antisense direction to the protein-coding SEPTIN7 gene. It is found on human chromosome 7q31.2. SEPT7-AS1 does not encode a protein, but regulates cellular processes at the RNA level—particularly gene expression regulation, cell cycle progression, DNA repair, apoptosis, and immune cell infiltration. Downregulation of SEPT7-AS1 is associated with poor prognosis in breast cancer and possibly other tumors. Its abnormal expression is found in various cancers and is considered to play a regulatory role in tumor progression, making it both a prognostic biomarker and a potential future therapeutic target. SEPTIN7 antisense RNA 1 is not a receptor, enzyme, or transporter, but rather a regulatory non-coding RNA. There are currently no approved drugs or experimental therapies specifically targeting this lncRNA, but it may be considered for therapeutic targeting or as a biomarker in oncology.

Other names
SEPTIN7-DTSEPT7-AS1SEPTIN7-AS1SEPT7 antisense RNA 1 (head to head)SEPTIN7 divergent transcript
02

Mechanism of action

no drugs currently, but potential future therapies may regulate its expression or function as an antisense molecule

03

Biological functions

Regulation of gene expressionCell cycle controlDNA repairApoptosisModulation of immune cell infiltrationRegulation of cell proliferation and migration
04

Disease associations

Cancer (notably breast cancer, laryngeal squamous cell carcinoma, glioma, and potentially others)Other (potential roles in additional cancers based on lncRNA function)
05

Biomarkers

Prognostic biomarker in breast cancer (low expression correlates with poor prognosis, advanced disease, and immune infiltration alterations)

Beyond the preview

Go deeper on SEPTIN7 antisense RNA 1 (SEPT7-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SEPTIN7 antisense RNA 1 (SEPT7-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call